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Abstract
Background: Macrophages are involved in a number of key physiological processes and complex
responses such as inflammatory, immunological, infectious diseases and iron homeostasis. These
cells are specialised for iron storage and recycling from senescent erythrocytes so they play a
central role in the fine tuning of iron balancing and distribution. The comprehension of the many
physiological responses of macrophages implies the study of the related molecular events. To this
regard, proteomic analysis, is one of the most powerful tools for the elucidation of the molecular
mechanisms, in terms of changes in protein expression levels.
Results: Our aim was to optimize a protocol for protein fractionation and high resolution mapping
using human macrophages for clinical studies. We exploited a fractionation protocol based on the
neutral detergent Triton X-114. The 2D maps of the fractions obtained showed high resolution and
a good level of purity. Western immunoblotting and mass spectrometry (MS/MS analysis) indicated
no fraction cross contamination. On 2D-PAGE mini gels (7 × 8 cm) we could count more than five
hundred protein spots, substantially increasing the resolution and the number of detectable
proteins for the macrophage proteome. The fractions were also evaluated, with preliminary
experiments, using Surface Enhanced Laser Desorption Ionization Time of Flight Mass
Spectrometry (SELDI-TOF-MS).
Conclusion:  This relatively simple method allows deep investigation into macrophages
proteomics producing discrete and accurate protein fractions, especially membrane-associated and
integral proteins. The adapted protocol seems highly suitable for further studies of clinical
proteomics, especially for the elucidation of the molecular mechanisms controlling iron
homeostasis in normal and disease conditions.
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Background
Macrophages are involved in a number of key physiologi-
cal processes and complex responses such as inflamma-
tory, immunological, infectious diseases and iron
homeostasis. Iron homeostasis is mainly controlled by
the liver-produced hepcidin peptide [1]. This small hor-
mone synchronizes systemic iron fluxes by binding to the
iron export channel ferroportin located on the surface of
macrophages, hepatocytes and intestinal enterocytes to
cause its internalization and proteolysis [2]. Ferroportin,
the only known cellular iron exporter, is highly expressed
on cells involved in iron export, including the duodenal
mucosa, macrophages and cells of the placenta. In macro-
phages, ferroportin is required for the efficient recycling of
iron from ingested erythrocytes [3].
In vivo, tissue macrophages are derived from circulating
monocytes recruited in the tissues by constitutive or
inflammatory signals [4,5]. Primary cultures of monocyte-
derived macrophages (MDMs) constitute a good model
for studying the biological activities of macrophages, and
are excellent candidates for a proteomic approach; in fact
they can be easily obtained and cultured within 12 days.
During this period they acquire many of the characteris-
tics of in vivo activated tissue macrophages, such as CD14
(LPS receptor)-expression [6], and the secretion of pro-
teases involved in remodelling the extracellular matrix [7].
Proteomic analysis is the most powerful method to eluci-
date the proteic effectors of cellular processes [8-10]. Two-
dimensional electrophoresis allows to map protein popu-
lations, to identify and underpin proteins whose expres-
sion levels correlate with particular responses or with
pathological states [11], generating information to desig-
nate protein markers specific for the disease. Sometime,
the analysis of total cell proteome poses practical chal-
lenges, due to its complexity (a thousand of proteins
expressed in a cell), to the great dynamic range of protein
expression and to the different protein properties (pI,
molecular mass, hydrophobicity, post-translational mod-
ifications). Suitable strategies to decrease such high com-
plexity are aimed at analysing subsets of the proteome,
e.g. by narrowing the pH range used for the first dimen-
sion [12], or by the sub-fractionation of proteins into
more homogeneous classes [13].
The analysis of single cellular compartments, fractionat-
ing the proteins into common localisation categories, e.g.
secreted components, membrane, nuclear, organelle's
proteins and cytosol, has given important practical advan-
tages and results offer a better insight into the protein
expression of each cell fraction considered [14-18]. Some-
times the isolation of proteome sub-sets has been
achieved with selective tagging methods for proteins, as in
the case of surface proteins, membrane-associated com-
ponents [19]. Alternatively, sequential extraction meth-
ods are used to collect proteins with physico-chemical
properties in-common [20].
Aimed at understanding the molecular mechanisms
occurring during the physiological responses of macro-
phages to different stimuli/environment/pathological
conditions, the proteome of such cells has been sub-
mapped in secretome, cytosol and membrane proteomes
[21,22]. Further optimisation of the protein extraction
method would results in higher resolution of the 2D
maps, with benefit in terms of comparative proteome
studies, thus permitting to expand significantly our
knowledge on macrophages and on their role in iron deal-
ing. MDMs are a good model for macrophages proteomic
studies, being easy to recruit, grow and mimicking well tis-
sues differentiated ones.
Here we report on the effective fractionation of cytosol
and membrane proteins of MDMs, by the adaptation of a
protocol that uses the neutral detergent Triton X-114,
whose peculiarity is the temperature-dependent solubil-
ity. The treatment proved to be very effective for fraction-
ating proteins on the basis of their hydropathicity [23].
Membrane, cytosol and secretome proteins have been run
on 2D gels. Mini gels allowed to count over 500 protein
spots, with very sharply focused spots. MS/MS on sampled
spots was used for deciphering the maps, indicating good
correlation between the fraction analysed and the protein
spot identified in the fraction. In preliminary experiments
we also assessed the obtained fraction by SELDI-TOF-MS
for hepcidin content, and we could detect a peptide with
the same mass as hepcidin only in the cytosolic fraction,
as expected.
Results & Discussion
Primary cultures of human MDMs were prepared by dif-
ferentiation of monocytes from blood donors according
to literature [24]. Optical microscope analysis showed a
good differentiation of MDMs in 12 days. The purity of
the cultures was evaluated as in ref. [24]; the flow cytom-
etry analysis permitted to assess the purity of the cultures
by testing positivity of macrophages to CD14 and CD45
(data not shown). Iron metabolism and macrophages are
closely linked; these specialized cells are devoted to iron
storage and recycling, expressing crucial proteic effectors
on the cell membrane such as ferroportin (the only
known iron-exporting-channel) and other soluble iron-
related proteins (IronRegulatoryProteins-IRPs, Ferritin,
etc.) [24]. While most of the genes and RNAs involved in
iron homeostasis have been described, still little is known
on the proteins deputed to such function. To unravel pro-
tein candidates of clinical interest, proteome analysis
appears as the reference technology for such investiga-
tions.Proteome Science 2009, 7:4 http://www.proteomesci.com/content/7/1/4
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Due to the complexity of an entire cell lysate from a pro-
teomic point of view, and willing to gain a wide range of
information, we decided to fractionate the sample prior to
2D electrophoresis.
Protein extraction from MDMs was obtained using a lysis
and fractionation protocol which distinguished proteins
on the basis of their hydropathicity. This method partially
derives from what achieved in [22,23] but was optimised
for MDM cell and allowed the sub-fractionation of the
total proteome of MDMs into intracellular proteome,
membrane proteome, membrane associated proteome
and secretome. In Figure 1 2D maps of the 4 fractions are
compared with the total lysate normally obtained with a
single step sample preparation, clearly showing the
increase in resolution and amount of information obtain-
able. For each fraction the number of protein spots
detected is also reported. Being most interested in the
membrane fraction, we extracted membrane proteins of
macrophages using the neutral detergent Triton X-114.
The fractionation protocol exploits the temperature
dependent solubility of Triton X-114. Fractionation steps
include mixing Triton X-114 with cell lysates at 0°C,
where it is freely soluble and where it forms complexes
associating hydrophobic proteins, followed by a step-wise
change in temperature, reaching Triton X-114 cloud point
(23°C), that induce the detergent precipitation, causing
the trapping of the protein complexes in an insoluble
phase. The treatment proved to be simple and very effec-
tive for fractionating membrane and cytosol proteins, per-
mitting to obtain high resolution 2D gels. A fraction of
"membrane associated" proteins was also recovered. The
use of neutral detergent Triton X-114 for MDM membrane
protein extraction was already demonstrated to give better
results in comparison to solvent extraction [22], even if it
was used only in conjunction with liquid chromatogra-
phy separations. Here we employed Triton X-114 and ana-
lysed extracted proteins by 2D electrophoresis and MS.
Upon lysis of human MDMs, the intracellular fraction was
recovered by precipitation of the supernatant. The pellet
of the lysis, containing the membranes was treated with
the neutral detergent Triton X-114 for protein extraction.
The protocol was adjusted for MDMs: the re-iteration in
sequence of the mixing steps with the detergent and incu-
bation steps ameliorated the protein-detergent complexa-
tion.
Fractions were run on 2D-PAGE (Minigel of 8 cm length)
and maps were analysed, after staining with Sypro Ruby,
by PDQuest software. After images digitalization it was
possible to highlight the presence of an elevated number
of spots in all the maps representative of the fractions (i.e.
527 ± 12, 232 ± 8, 408 ± 11 in the intracellular, membrane
and membrane associated fraction, respectively). These
spots number accounts for a good quality and high reso-
lution protein profiles. The quality of the fractions recov-
ered (intracellular and membrane) was assessed by SDS-
PAGE electrophoresis followed by MS-MS or Western
blotting. Intracellular fraction was assayed for the pres-
ence of the cytosolic enzyme phosphoglycerate kinase
(PGK I), a protein typical of the glycolytic pathway and for
the absence of membrane protein contamination, (Figure
2, panels A-B), by incubating the same Polyvinylidene
Fluoride (PVDF) membrane with an antibody against the
matrix metallopeptidase 9 (MMP-9).
The three main fraction were run on the same SDS-PAGE
and equal amount of total protein were loaded in each
lane. Only the lane referring to the cytosolic fraction
showed a distinct band when developed with the anti-
PGK1 antibody, being clear the presence of the enzyme
only in there and thus indicating no major contamination
between fractions. In addition, only the lane referring to
the membrane fraction showed a distinct band when
developed with the anti MMP-9 antibody, indicating no
contamination of the cytosolic fraction by membrane pro-
teins.
Figure 3 shows some comparisons between selected zones
of the total extract and the corresponding zone on 2D gels
of fractions, highlighting the different resolution achieved
when proteins where fractionated prior to the 2D run. In
analogy with membrane proteome literature [25], the
recovery of integral and membrane associated proteins
was successfully obtained with the use of detergents,
because their lipophilic character mimics the native lipid-
membrane environment. A quantitative evaluation of the
2D maps was performed by comparing the results of spots
image analysis of the membrane fraction with those of the
total extract. It was evident that, in the selected zones (Fig-
ure 3), the increase in spot density resulted 2.1 fold, thus
indicating the substantial improvement in density gained
with the fractionation. The membrane fraction was also
subjected to qualitative studies. MS analysis of a sample of
21 spots from the membrane fraction gave the identifica-
tions shown in Table 1 (the cut spots are indicated with
circles in the map in Figure 4). Among these proteins, 10
are integral membrane proteins and the remaining pro-
teins are all associated to the plasma membrane or to
membrane proteins, being 90% the total recovery percent-
age. These results support the Triton X114 extraction
method for MDMs membrane protein studies. Figure 3D
reports the number of protein counted in each fraction
and the count of the map of the total extract. The number
of proteins doubles in case of fractionation, also indicat-
ing the great advantage of the chosen protocol. The frac-
tionation of the samples enabled to increase the amount
of information achievable on the protein effectors in mac-
rophages. All the four compartments analysed can be fur-Proteome Science 2009, 7:4 http://www.proteomesci.com/content/7/1/4
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2D-Maps representing total protein extract from macrophages and protein fractions derived from the proposed protocol Figure 1
2D-Maps representing total protein extract from macrophages and protein fractions derived from the pro-
posed protocol. 2D mini gels of a total protein extract from macrophages cells (panel on the left) and the 4 fractions 
obtained by applying the extraction protocol with Triton X114 (cytosolic fraction, membrane fraction, membrane associated 
fraction and secretome fractions, from the top to the bottom). All the 2D-PAGE are run on a 3–10 non linear IPG strip and an 
equal amount of total protein content was loaded on each gel. For each 2D map the spots count, as obtained with PDQuest 
software, is indicated.Proteome Science 2009, 7:4 http://www.proteomesci.com/content/7/1/4
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ther studied and evaluated in terms of specific enzymes or
antigens.
Being interested in iron metabolism we also evaluated the
fractions in term of hepcidin content (see the additional
files 1 and 2 for SELDI-TOF-MS method details and fig-
ure). Hepcidin is the master regulator of iron homeostasis
and acts by tuning iron influx into plasma from tissues
dedicated to iron storage or transport. In particular mac-
rophages recycle iron from senescent entherocytes. Our
interest was to monitor hepcidin presence in the fraction
in order to study its behavior in cultured macrophages. In
preliminary experiments, a peptide matching the mass of
hepcidin was detectable only in the cytosol but not in the
other compartments (see additional file 2).
Notwithstanding recent progress, much work remains to
be done in defining the role of hepcidin in both healthy
and diseased states. However, to date, few investigative
tools are available [26-29]. By means of SELDI-TOF-MS
technology, we and others were successful to detect hepci-
din and its isoforms in urine and serum [1,30,31]. Our
preliminary results appear to confirm the presence of hep-
cidin in macrophages also as protein, extending the data
reported by Theurl and colleagues about hepcidin mRNA
in monocyte/macrophages [32]. The presence of a peptide
of the same mass as hepcidin in the cytosolic fraction is in
agreement with the known cycle of hepcidin from liver to
cells, by means of binding to ferroportin and internaliza-
tion [1,2,33]. We are going to validate this approach
investigating other MDMs under different conditions.
Further experiments are needed for a better understanding
of the peptide behavior regarding its binding to mem-
brane proteins. The mutual interaction of hepcidin with
ferroportin is essential for the understanding of iron
homeostasis in the cells [34] and the study of MDMs from
patients and/or animal models of ferroportin disease [35]
could give new insights into this field.
Conclusion
The purpose of this work was to find a feasible method for
the study of cytosolic, integral membrane, membrane
associated and secreted proteins in comparative proteom-
ics experiments of clinically relevant samples. This tech-
nique, based on Triton X-114, allowed us to obtain high
resolution 2D maps for all the fractions. The fractionation
and extraction method gave as an improvement in spots
number detectable and amount of information achieva-
ble. In particular the results obtained mapping membrane
proteins are remarkable: the maps show high quality
spots and no streaks. In fact membrane proteins, due to
their hydrophobicity, usually focus poorly using the con-
Western blot analysis for PGK-1 presence in the obtained fractions Figure 2
Western blot analysis for PGK-1 presence in the obtained fractions. Western blot analyses for the cytosolic enzyme 
phosphoglycerate kinase (PGK I), typical of the glycolysis, panel A, and for the membrane bound protein Metalloproteinase 9 
(MMP9), panel B. The three fractions were run together on the same SDS-PAGE loading an equal amount of total protein. The 
same PVDF membrane was used. Film image with the relative protein bands only in the lane corresponding to the cytosolic 
compartment and to the membrane fraction are reported. Western blot images were captured by GS710 densitometer (Bio-
Rad) and analyzed by QuantityOne software.
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Comparison between total extract 2D map and fractions 2D maps Figure 3
Comparison between total extract 2D map and fractions 2D maps. 2D gels of total extract and fractions with 
enlargements of specific zones and a diagram reassuming the numerical data obtained. A) total extract versus membrane frac-
tion. B) total extract versus cytosolic fraction. C) total extract versus membrane associated fraction. D) Pie chart representing 
the Spots counts relative to the total extract (left panel) and the summary of the 4 fractions obtained with the proposed pro-
tocol.
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ventional isoelectrofocusing (IEF) procedure, often lead-
ing to horizontal streaks. Mapping separately the protein
population of macrophages, in healthy and disease condi-
tions, would allow a deeper understanding of Hereditary
Hemochromatosis and iron related disorders.
Methods
Monocyte Derived Macrophages Coltures
Peripheral blood mononuclear cells were isolated from
healthy human blood donors attending to the Transfu-
sion Service, University Hospital of Verona.
Primary cultures of human MDMs were prepared as
described by Pinet [24] with minor changes. Monocytes
were left to differentiate in a RPMI medium, containing 2
mM streptomycin, 2 mM Gln, and 10% FCS. Monocytes
purity was tested by flow cytometer, according to ref [24]
quality criteria.
Cell lysis
After the differentiation, cells were lysed as in ref [22] with
some modifications. Lysis solution was 10 mM HEPES, 10
mM KCl, protease inhibitor (Mini-Complete Roche). Cell
were washed 4–5 times with 10 mL DPBS at room temper-
ature. The washes were collected and pooled for secre-
tome analysis. Three mL of cold lysis buffer were added
and incubate 10 min. Cells were scraped from the surface
and centrifuged 25 min at 16000 g. Cytoplasm was recov-
ered as supernatant, membranes as pellet.
Extraction of secreted proteins
The culture media were pooled and the proteins precipi-
tated for 1 h at 0°C by adding 15% TCA. The protein pel-
lets were collected by centrifuging at 13000 g for 10
minutes at 4°C and washed two times with 1 mL of cold
acetone. The pellets were then resuspended in buffer con-
taining 2 M tiourea, 7 M urea, 3% CHAPS, 20 mM Tris,
and protein concentration was determined by Bradford
assay using BSA as standard.
Extraction of intracellular (cytosol) proteins
The supernatant was precipitated overnight at -20°C with
acetone: methanol (8:1 vol/vol), then centrifuged 20 min
at 18300 g; the pellet was recovered, let dry and re-sus-
pended in 7 M urea, 2 M thiourea, 3% CHAPS, 20 mM
Tris, 1% ampholytes and centrifuged 40 min at 18300 g to
precipitate DNA contaminants (dark pellet on the bottom
of the eppendorf).
Extraction of membrane proteins
The extraction buffer is prepared with 2% Triton X-114 in
TBS (150 mM NaCl, 10 mM Tris-HCl pH 7.6). The extrac-
tion is conducted on ice. The membrane pellet is re-sus-
pended in 100 μl MilliQ water and added of 500 μl
extraction buffer, then 1) homogenised with a small
syringe, 2) let stand in ice for 1 min, 3) vortex for 1 min,
4) let stand in ice for 1 min. The four steps are repeated
five times and then the sample is kept on ice for 10 min,
vortexed, and finally put 1 hour at 37°C. The sample is
then centrifuged for 5 min at 16000 g at room tempera-
ture. The lower phase contains Triton X-114 with the
membrane proteins, the upper phase contains the aque-
ous phase and proteins. The two phases are collected and
each one is precipitated overnight at -20°C with acetone:
methanol (8:1 vol/vol), then centrifuged 20 min at 18300
g. Each pellet was recovered, let dry and re-suspended in 7
M urea, 2 M thiourea, 3% CHAPS, 20 mM Tris.
Extraction of membrane-associated proteins
The upper phase, expected to be enriched in hydrophilic
proteins, collected during the extraction of membrane
proteins, was precipitated overnight with cold ace-
tone:methanol (8:1 vol/vol) at -20°C. The protein pellets
were recovered by centrifugation at 18300 g for 20 min-
utes at 4°C. The pellets were then resuspended in buffer
containing 2 M thiourea, 7 M urea, 3% CHAPS, 20 mM
Tris, and protein concentration was determined by Brad-
ford assay.
Control of fraction purity by western immunoblotting
Protein fractions were separated by SDS-PAGE and immu-
nodetected with antibody specific for a cytosolic protein
(PGK I) and a membrane bound protein (MMP9) by
Western blot to verify the efficiency of separation proto-
col. Protein extracts were diluited 1:1 with Laemmli's sam-
2D map of the membrane fraction used for spot excision and  ID Figure 4
2D map of the membrane fraction used for spot exci-
sion and ID. 2D gel of the membrane fraction showing the 
cut spots as red circles numbered from 1 to 21.
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Table 1: membrane fraction identified proteins
SSP Mw, kDa theor./exp. pI predict./exp. No. of peptides 
identified
Mascot Score NCBI Accession 
Number
Protein ID
5 51372 8.88 11 592 gi|872121 isocitrate 
dehydrogenase 
(NADP+)
[Homo sapiens]
38780 7.57 21 1301 gi|18645167 Annexin A2
[Homo sapiens]
21 38639 6.32 3 162 gi|190200 Porin
[Homo sapiens]
42128 5.22 4 198 gi|28336 mutant beta-actin 
(beta'-actin)
[Homo sapiens]
17 18537 5.21 2 70 gi|5453559 ATP synthase, H+ 
transporting, 
mitochondrial F0 
complex, subunit d 
isoform a
[Homo sapiens]
58411 7.58 17 1101 gi|35505 pyruvate kinase
[Homo sapiens]
13 59828 9.16 2 113 gi|4757810 ATP synthase, H+ 
transporting, 
mitochondrial F1 
complex, alpha 
subunit precursor
[Homo sapiens]
1 53738 5.03 36 1940 gi|340219 Vimentin
[Homo sapiens]
14 42080 5.37 6 317 gi|62897625 beta actin variant
[Homo sapiens]
15 12905 5.77 3 70 gi|34616 beta-2 microglobulin
[Homo sapiens]
12 59785 9.07 20 1136 gi|127798841 ATP synthase, H+ 
transporting, 
mitochondrial F1 
complex, alpha 
subunit 1, cardiac 
muscle
[Homo sapiens]
10 29843 5.57 9 485 gi|4505773 prohibitin
[Homo sapiens]
3 50810 5.02 25 651 gi|37492 alpha-tubulin
[Homo sapiens]
18 30737 8.63 7 420 gi|238427 Porin 31HM [human, 
skeletal muscle 
membranes, 
Peptide, 282 aa]
[Homo sapiens]Proteome Science 2009, 7:4 http://www.proteomesci.com/content/7/1/4
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ple buffer (62.5 mM Tris-HCl, pH 6.8, 25% glycerol, 2%
SDS, 0.01% bromophenol blue, 5% β-mercaptoethanol),
boiled for 3 min and separated by SDS-PAGE on 12% T
acrylamide gels in Tris/glycine/SDS buffer. Proteins were
then electroblotted onto PVDF membranes (Biorad) at 60
V for 2 h at 4°C. Non specific sites were blocked by incu-
bating with 3% non-fat dried milk and 0.05% Tween-20
(Sigma-Aldrich) in Tris-buffered saline (TBS-T) for 1 h at
37°C. Membranes were incubated overnight at room tem-
perature with the primary antibody for PGK I (Sigma-
Aldrich) diluited 1:500, in 3% non-fat dried milk and
0.05% Tween-20 (Sigma-Aldrich) in TBS and with the pri-
mary antibody for MMP-9 (Sigma-Aldrich) diluted
1:1000 in 3% non-fat dried milk and 0.05% Tween-20
(Sigma-Aldrich) in TBS. Membranes were washed four
times for 15 min with TBS-T and then were incubated for
1 h at room temperature with the appropriate horseradish
peroxidase-conjugated secondary antibody: ECL anti-goat
IgG horseradish peroxidase-linked (Sigma-Aldrich) at
1:20000 diluition for PGK I and ECL anti-rabbit IgG
horseradish peroxidase-linked (Sigma-Aldrich) at 1:5000
diluition for MMP-9. Membranes were washed three
times for 15 min with TBS-T and once for 15 min with
TBS. Finally the immunocomplexes were detected by
chemiluminescence (ECL, GE Healthcare,) on X-ray X-
Omat AR (Kodak, Rochester, NY, USA) films. The West-
ern-blot image was obtained by scanning films using
Quantity One software Version 4.4 (Biorad).
11 30337 6.99 3 178 gi|4758788 NADH 
dehydrogenase 
(ubiquinone) Fe-S 
protein 3, 30 kDa 
(NADH-coenzyme Q 
reductase)
[Homo sapiens]
20 49851 7.70 20 710 gi|704416 elongation factor Tu
[Homo sapiens]
16 42052 5.29 5 131 gi|4501885 beta actin
[Homo sapiens]
7 42080 5.37 8 398 gi|62897625 beta actin variant
[Homo sapiens]
2 48083 4.95 17 1052 gi|89574029 mitochondrial ATP 
synthase, H+ 
transporting F1 
complex beta 
subunit
[Homo sapiens]
8 53559 5.93 4 189 gi|32709 IFP53
[Homo sapiens]
6 42080 5.37 8 371 gi|62897625 beta actin variant
[Homo sapiens]
4 53297 5.94 6 241 gi|46593007 ubiquinol-
cytochrome c 
reductase core 
protein I
[Homo sapiens]
19 53809 6.03 19 1278 gi|40889610 Chain A, Crystal 
Structure Of Human 
Tryptophanyl-Trna 
Synthetase
[Homo sapiens]
Identified proteins from membrane fraction. The corresponding standard spot number (SSP) and the parameters of identifications are also 
indicated.
Table 1: membrane fraction identified proteins (Continued)Proteome Science 2009, 7:4 http://www.proteomesci.com/content/7/1/4
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2D electrophoresis
Proteins samples (100 μg for intracellular proteins, 100 μg
for membrane proteins, 100 μg for membrane-associated
proteins and 100 μg for secreted proteins) were mixed
with solubilization buffer (2 M thiourea, 7 M urea, 3%
CHAPS, 20 mM Tris) to obtain a final volume of 150 μl.
Each sample was reduced and alkylated with 5 mM trib-
utylphosphine and 10 mM acrylamide. The mixture was
then applied to the dry gel strip (IPG 70 mm, pH 3–10
non linear gradient) for reswelling. Focusing was per-
formed at 300 V for 2 h, 400 V for 1 h, 1000 V for 6 h,
2000 V for 2 h, 3500 V for 5 h, 5000 V until the complete
focalization (25000 Vxh). The current was limited to 50
μA per strip, and the temperature was kept at 20°C for all
IEF steps. For SDS-PAGE, the IPG strips were incubated in
equilibration buffer (6 M urea, 2% SDS, 20% glycerol,
0.375 M Tris-HCl pH 8.8) for 26 minutes and then trans-
ferred to the second dimension onto 10%–20% T gradient
acrylamide gels. The gels were run 5 mA per gel for 1 h, 10
mA per gel for 1 h and 20 mA per gel until the bromophe-
nol blue front had reached the bottom of the gel. The 2-
DE gels were stained in Sypro Ruby: the proteins were first
fixed in a solution of 7% acetic acid and 10% methanol
for 1 h, then incubated in Sypro Ruby overnight and
finally destained in 7% acetic acid and 10% methanol for
2 h. Sypro Ruby stained 2-DE gels were digitized using
VersaDoc (BioRad, Hercules, CA) and bioinformatic anal-
ysis was performed with PDQuest 7.3.0 (BioRad).
Mass spectrometry analysis
In-Gel-Digestion
Protein spots were carefully cut out from Sypro Ruby
stained gels and subjected to in-gel trypsin digestion
according to Shevchenko and colleagues with minor mod-
ifications [36]. The gel pieces were swollen in a digestion
buffer containing 50 mM NH4HCO3 and 12.5 ng/μL of
trypsin (modified porcine trypsin, sequencing grade,
Promega, Madison, WI) in an ice bath. After 30 min, the
supernatant was removed and discarded, 20 μL of 50 mM
NH4HCO3 was added to the gel pieces, and digestion was
allowed to proceed at 37°C overnight. The supernatant
containing tryptic peptides was dried by vacuum centrifu-
gation. Prior to mass spectrometric analysis, the peptide
mixtures were redissolved in 10 μL of 5% Formic Acid.
Protein Identification by nano-HPLC-MS/MS
Peptide mixtures were separated using a nanoflow-HPLC
system (Ultimate; Switchos; Famos; LC Packings, Amster-
dam, The Netherlands). A sample volume of 10 μL was
loaded by the autosampler onto a homemade 2 cm fused
silica precolumn (75 μm i.d.; 375 μm o.d.; Reprosil C18-
AQ, 3 μm (Ammerbuch-Entringen, DE)) at a flow rate of
2  μL/min. Sequential elution of peptides was accom-
plished using a flow rate of 200 nL/min and a linear gra-
dient from solution A (2% acetonitrile and 0.1% formic
acid) to 50% of solution B (98% acetonitrile and 0.1%
formic acid) in 40 min over the precolumn in-line with a
homemade 10–15 cm resolving column (75 μm i.d.; 375
μm o.d.; Reprosil C18-AQ, 3 μm (Ammerbuch-Entringen,
Germany)).
Peptides were eluted directly into a High Capacity ion
Trap (model HCTplus, Bruker-Daltonik, Germany). Cap-
illary voltage was 1.5–2 kV and a dry gas flow rate of 10 L/
min was used with a temperature of 230°C. The scan
range used was from 300 to 1800 m/z. Protein identifica-
tion was performed by searching in the National Center
for Biotechnology Information nonredundant database
(NCBInr) using the Mascot program http://www.matrix
science.com. The following parameters were adopted for
database searches: complete carbamidomethylation of
cysteines and partial oxidation of methionines, peptide
mass tolerance ± 1.2 Da, fragment mass tolerance ± 0.9
Da, missed cleavages 2. For positive identification, the
score of the result of (-10 Log(P)) had to be over the sig-
nificance threshold level (P < 0.05).
Even though high MASCOT scores are obtained with val-
ues greater than 60, when proteins were identified with
only one peptide, a combination of automated database
search and manual interpretation of peptide fragmenta-
tion spectra was used to validate protein assignments. In
this manual verification, the mass error, the presence of
fragment ion series, and the expected prevalence of C-ter-
minus containing (Y-type ions) in the high mass range
were all taken into account. Moreover, replicate measure-
ments have confirmed the identity of these protein hits.
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